Adama Ltd. Class A SZSE:000553
ADAMA : Third Quarter 2025 Q&A Filings
Source: MarketScreener
Stock Code: 000553(200553) Stock Abbreviation: ADAMA A(B) Announcement No.2025-33
The Company and all members of its board of directors hereby confirm that all information disclosed herein is true, accurate and complete with no false or misleading statement or material omission.
ADAMA LTD. THIRD QUARTER REPORT 2025
ADAMA Ltd. (hereinafter referred to as "the Company") is a global leader in crop protection, providing solutions to farmers across the world to combat weeds, insects and disease. ADAMA has one of the widest and most diverse portfolios of active ingredients in the world, state-of-the art R&D, manufacturing and formulation facilities, together with a culture that empowers our people in markets around the world to listen to farmers and ideate from the field. This uniquely positions ADAMA to offer a vast array of distinctive mixtures, formulations and high-quality differentiated products, delivering solutions that meet local farmer and customer needs in dozens of countries globally, with direct presence in all top 20 markets.
Please see important additional information and further details included in the Annex. October 2025 Important Notice The Company's Board of Directors, Board of Supervisors, directors, supervisors and senior managers confirm that the content of the Report is true, accurate and complete and contains no false statements, misleading presentations or material omissions, and assume joint and several legal liability arising therefrom. Gaël Hili, the person leading the Company (Pres ident and Chief Executive Officer) as well as its legal representative, and Efrat Nagar, the person leading the accounting function (Chief Financial Officer), hereby assert and confirm the truthfulness, accuracy and completeness of the Financial Report. The Third Quarter Report has not been audited. This Report has been prepared in both Chinese and English. Should there be any discrepancy between the two versions, the Chinese version shall prevail.Main accounting and financial results
Whether the Company performs any retroactive adjustments to, or restatements of, its accounting data of last year due to change in accounting policies or correction of accounting errors
Yes √ No
July - September 2025
+/- (%)
January -September 2025
+/- (%)
Operating revenues (RMB'000)
6,654,225
0.62%
21,678,425
0.72%
Net loss attributable to shareholders of the Company (RMB'000)
(342,454)
63.69%
(422,806)
77.00%
Net loss attributable to shareholders of the Company excluding non-recurring profit and loss (RMB'000)
(372,499)
61.92%
(522,256)
72.87%
Net cash flow from operating activities (RMB'000)
635,282
-43.84%
2,373,860
-17.06%
Basic EPS (RMB/share)
(0.1470)
63.69%
(0.1815)
77.00%
Diluted EPS (RMB/share)
N/A
N/A
N/A
N/A
Weighted average return on net assets
(1.82%)
2.71 pp
(2.26%)
6.46 pp
End of Reporting Period
End of last year
+/- (%)
Total assets (RMB'000)
49,930,633
50,059,777
-0.26%
Net assets attributable to shareholders (RMB'000)
18,453,345
18,991,094
-2.83%
Non-Recurring profit/loss
√ Applicable □ Not applicable
Unit: RMB'000
Item
July -September
2025
January -September
2025
Note
Gains/losses on the disposal of non-current assets (including the offset part of asset impairment provisions)
9,545
14,599
-
Government grants recognized through profit or loss (excluding government grants closely related to business of the Company and given at a fixed quota or amount in accordance with government's uniform
standards)
7,827
12,938
-
Custodian fees earned from entrusted operation
2,574
2,574
-
Recovery or reversal of provision for bad debts which is assessed individually during the years
8,298
46,445
-
Post vesting fair value revaluation of cash-settled share based payment
4,414
11,992
-
Gains or losses arising from the holding or disposal of financial assets or financial liabilities by non-financial corporations, except for effective hedging related to the
normal operating of the Company
-
30,714
-
Other non-operating income and expenses other than the above
2,160
3,980
-
Less: Income tax effects
4,773
23,792
-
Total
30,045
99,450
-
Explanation of other profit or loss that meets the definition of non-recurring profit or loss
Applicable √ Not applicable
No such cases in the Reporting Period.
Explanation of why the Company classified an item as non-recurring profit/loss according to the definition in the Explanatory Announcement No. 1 on Information Disclosure for Companies Offering their Securities to the Public. Non-recurring Profit and Loss, and reclassified any non-recurring profit/loss items are given as examples in the said explanatory announcement to recurrent profit/loss
Applicable √ Not applicable
No such cases in the Reporting Period.
Changes in main accounting statement items and financial indicators in the Reporting Period, as well as reasons for the changes
√ Applicable □ Not applicable
General Crop Protection (CP) Market Environment1Through the first nine months of 2025, channel inventory returned to pre-pandemic levels in most countries, allowing crop protection demand recovery. Pricing pressure remains high, driven by production over-capacity of active ingredients. Crop commodity prices remain stably low and coupled with the high-interest rate environment, farmer profitability remains tight leading to just-in-time purchasing patterns.
Geopolitical SituationADAMA is headquartered and has three manufacturing sites in Israel. The regional tensions which escalated on October 7, 2023, continued to have no material impact to-date on the Company's ability to support its markets or its consolidated financial results.
ADAMA is a global company with manufacturing and formulation facilities in several locations around the world, principally in Israel, China and Brazil. The Company's management appointed a dedicated task force to analyze implications of US tariff policies and to closely monitor and manage the situation and its potential impact on its global network. Despite the uncertainty regarding the US tariff policies, the Company currently expects that the impact on its operations and business results will be immaterial.
January -September 2025 (000'RMB)
Same period last year (000'RMB)
+/-%
January -September 2025 (000'USD)
Same period last year (000'USD)
+/-%
Operating income (Revenues)
21,678,425
21,523,293
0.72%
3,024,742
3,027,945
-0.11%
Cost of goods sold
16,004,956
16,748,146
-4.44%
2,233,171
2,356,131
-5.22%
Sales & Marketing expenses
2,950,375
3,408,333
-13.44%
411,737
479,481
-14.13%
General & Administrative expenses
1,089,510
817,172
33.33%
152,041
114,955
32.26%
R&D expenses
307,417
319,977
-3.93%
42,890
45,014
-4.72%
Financial Expenses
1,544,466
1,220,073
26.59%
215,373
171,629
25.49%
1Sources: AgbioInvestor Quarterly report (September 2025), peer quarterly financial results, internal sources.
January -September 2025
(000'RMB)
Same period last year (000'RMB)
+/-%
January -September 2025
(000'USD)
Same period last year (000'USD)
+/-%
Gain (Loss) from Changes in Fair Value
4,781
(235,775)
102.03%
574
(33,184)
101.73%
Total Net Financial Expenses
1,539,685
1,455,848
5.76%
214,799
204,813
4.88%
Total loss
(417,446)
(1,442,604)
71.06%
(58,307)
(202,873)
71.26%
Income tax expenses
5,360
395,508
-98.64%
801
55,643
-98.56%
Net loss attributable to shareholders of the Company
(422,806)
(1,838,112)
77.00%
(59,108)
(258,516)
77.14%
EBITDA
2,706,104
1,790,580
51.13%
377,526
251,953
49.84%
Q3 2025 (000'RMB)
Q3 2024 (000'RMB)
+/-%
Q3 2025 (000'USD)
Q3 2024 (000'USD)
+/-%
Operating income (Revenues)
6,654,225
6,613,004
0.62%
933,411
929,451
0.43%
Cost of goods sold
4,974,783
5,274,072
-5.67%
697,816
741,264
-5.86%
Sales & Marketing expenses
974,707
1,044,957
-6.72%
136,724
146,867
-6.91%
General & Administrative expenses
354,643
280,906
26.25%
49,739
39,480
25.99%
R&D expenses
90,624
101,870
-11.04%
12,713
14,319
-11.22%
Financial Expenses
520,126
596,427
-12.79%
72,943
83,826
-12.98%
Gain (Loss) from Changes in Fair Value
11,274
(39,283)
128.70%
1,581
(5,525)
128.62%
Total Net Financial Expenses
508,852
635,710
-19.96%
71,362
89,351
-20.13%
Total loss
(291,867)
(871,175)
66.50%
(40,903)
(122,441)
66.59%
Income tax expenses
50,587
72,072
-29.81%
7,096
10,129
-29.94%
Net loss attributable to shareholders of the Company
(342,454)
(943,246)
63.69%
(47,999)
(132,570)
63.79%
EBITDA
741,865
395,826
87.42%
104,087
55,636
87.09%
Note: Since the functional currency of main overseas subsidiaries is the USD, and the Company's management review of the Company's performance is based on the USD results, following explanations and analysis are based on USD-denominated numbers as listed above.
Analysis of Financial HighlightsRevenues
Revenues in the third quarter were stable (1% in RMB; 0% in CER) reaching $933 million, mainly reflecting the combined results of a 1% increase in volume and a 1% decrease in prices. The higher volumes reflected the gradual recovery of market demands and improvement of channel inventories in most regions. Prices remained weak mainly due to low prices of active ingredients in light of overcapacity, as well as a high-interest rate environment and low commodity prices, which put pressure on distributors and farmers.
Revenues in the first nine months were also stable (1% in RMB; 1% in CER) reaching $3,025 million. The stabilization of revenues in the first nine months was driven by volume growth of 3% offsetting a decrease in prices of 3%.
Regional Sales PerformanceQ3 2025
$m
Q3 2024
$m
Change USD
9M 2025
$m
9M 2024
$m
Change USD
Europe, Africa & Middle East (EAME)2
233
216
8%
903
911
-1%
North America
164
158
4%
659
572
15%
Latin America
312
287
9%
675
687
-2%
Asia Pacific3
225
269
-16%
789
859
-8%
Of which China
91
109
-17%
400
384
4%
Total
933
929
0%
3,025
3,028
0%
Note: the numbers in this table may not sum due to rounding.
Europe, Africa & Middle East (EAME): Volumes and revenue in EAME increased in the third quarter, though significant declines in Turkey in the first quarter impacted the year-to-date results. Pricing continued to decline in light of intense competition. Foreign exchange rates had positive impact in the third quarter.
North America: In the US Ag market, though slightly down in the third quarter, was significantly up in the first nine months following improvements in volumes and prices. Similarly in Canada, while the third quarter was flat with an increase in volume offset by a decrease by prices, for the nine months volumes are significantly up. Consumer & Professional Solutions experienced increased volumes and flat prices for both the third quarter and year-to-date.
Latin America: In Brazil, revenues were significantly up in the third quarter, resulting in higher revenues also for the first nine months compared to the previous year. Growth was driven by increased volumes, while the third quarter also experienced modest pricing increases. In the rest of LATAM lower volumes, prices, and revenues were reported in the third quarter and the first nine months, primarily in Paraguay and Argentina, due to channel destocking and just-in-time purchasing behavior.
Asia-Pacific: India experienced significant declines in the third quarter revenues, primarily due to lower volumes driven by extreme weather conditions and lower prices. In the rest of APAC (excluding India and China), sales and volumes were
2As part of ADAMA's business optimization program, on January 1, 2025, South Africa was reclassified from the APAC region to EAME. To enable meaningful comparisons, the 2024 data presented here includes South Africa under EAME.
slightly up for the quarter, despite ongoing pricing pressures.
In China, sales in the third quarter mainly reflected the impacts of lower non-ag sales, partially compensated by the increase of AI sales. Non-ag sales declined following implementation of the Company's strategic decision to pivot away from manufacturing some basic chemical products, and weaker market demands. Higher AI sales were driven by volume growth due to the expansion of new distribution channels and supported by the recovery of global demand. Sales of the formulations business stabilized, still reflecting relatively high channel inventories and severe market competition. Supported by the growth in the first half, sales in China in the first nine months increased compared to last year.
Cost of Goods and Gross Profit
The higher gross profit and margin in the third quarter and first nine months mainly reflected the positive impacts of lower costs due to improved operational efficiency and lower costs of inventory sold as well as higher volume, more than compensating for lower prices.
Operating Expenses:
Operating expenses include Sales and Marketing, General and Administration and R&D.
The operating expenses in both the third quarter and first nine months were lower mainly because last year there were one-off expenses related to a legal claim of product liabilities which offset the higher restructuring and advisory costs in 2025. In the third quarter, the benefits were offset by the increase in expenses attributed to company success-based employee compensation due to improved 2025 results to-date. In the first nine months, the positive impacts following implementation of the Fight Forward plan in 2025 and that in H1 last year an update of registration amortization was recorded contributed to the decrease in operating expenses.
In addition to that, for Q3 and 9M of both 2024 and 2025, the Company continued recording following charges in its sales and marketing expenses at a similar amount, which incurred due to mergers and acquisitions in recent years, mainly: (i) non-cash amortization charges in respect of transfer assets received from Syngenta related to the 2017 ChemChina-Syngenta acquisition; and (ii) non-cash amortization net charges related to intangible assets created as part of the Purchase Price Allocation (PPA) on acquisitions, with no impact on the ongoing performance of the companies acquired.
Non-operational charges affected the Company's reported operating expenses amounting to RMB 176 million ($25 million) in Q3 2025 in comparison to RMB 167 million ($23 million) in Q3 2024, and RMB 519 million ($73 million) in 9M 2025 in comparison to RMB 639 million ($90 million) in 9M 2024. For details of the non-operational charges, please refer to the Annex to the Report.
Financial Expenses
"Financial Expenses" alone mainly reflect interest payments on corporate bonds and bank loans as well as foreign exchange gains/losses on the bonds and other monetary assets and liabilities before the Company carries out any hedging. The impact of Financial Expenses (before hedging) is an expense of RMB 1,544 million ($215 million) for the nine months of 2025 compared with an expense of RMB 1,220 million ($172 million) for the corresponding period in 2024.
Given the global nature of its operational activities and the composition of its assets and liabilities, the Company, in the ordinary course of its business, uses foreign currency derivatives (forwards and options) to hedge the cash flow risks associated with existing monetary assets and liabilities that may be affected by exchange rate fluctuations. "Gains/Losses from Changes in Fair Value" which recorded the hedging costs and impacts among others amounted to a net gain of RMB 5 million ($0.6 million) in the first nine months of 2025, compared with a net loss of RMB 236 million ($33 million) in the corresponding period in 2024.
The aggregate of Financial Expenses and Gains/Losses from Changes in Fair Value (hereinafter as "Total Net Financial Expenses"), which more comprehensively reflects the financial expenses of the Company in supporting its main business and protecting its monetary assets/liabilities, amounts to RMB 1,540 million ($215 million) in the nine months of 2025 compared with RMB 1,456 million ($205 million) in the corresponding period in 2024.
In the first nine months, Total Net Financial Expenses increased mainly because in 2024 there was a RMB 239 million ($34 million) income from revaluation of the put options attributed to minority stakes in controlled subsidiaries. Excluding this one-time gain last year, Total Net Financial Expenses were lower in the first nine months primarily positively impacted by a bond buyback that was executed in late Q2 by a fully-controlled subsidiary of the Company, as well as the lower hedging costs related to the Israeli Shekel.
Income Tax Expenses
The Company recorded tax expenses mainly because losses that were primarily incurred by subsidiaries with relatively lower tax rates, while some of them did not create deferred tax assets on the losses. On the other hand, the subsidiaries that generated profit have a higher tax rate.
The tax expenses in first nine months of 2025 are lower compared to the first nine months of 2024 due to (1) lower losses in subsidiaries that did not create deferred tax assets; (2) tax income raised by the accounting method of calculation of tax assets related to unrealized profits; and (3) foreign exchange impact of the stronger BRL in 2025 compared with tax expenses due to the weakness of the BRL in the first nine month of 2024.
Changes in main assets and liabilities
Unit: RMB'000
Assets and liabilities
End of Reporting
Period
End of last year
+/- (%)
Explanation
Derivative financial assets
334,747
483,822
-30.81%
Change due to realization and revaluation of derivatives
Other receivables
640,870
1,147,469
-44.15%
Mainly decrease in receivables in respect of securitization transaction
Bills payable
647,860
439,495
47.41%
Increase in the procurement of goods
Other payables
1,872,012
1,417,319
32.08%
Mainly increase in liabilities in respect of securitization transaction and accrued expenses
Short-term loans
6,394,069
4,748,720
34.65%
Debt replacement
Long-term loans
1,442,948
2,166,625
-33.40%
Repaid loans
Use of Raised Funds
Applicable √ Not applicable
No such cases in the Reporting Period.
Information regarding the Shareholders
Total number of ordinary shareholders and preference shareholders who had resumed their voting rights, and shareholdings of top 10 shareholders at the period-end
Unit: share
Total Number of Common Shareholders as of the End of the
36,215 (the number of ordinary A share shareholders is 24,837; the
Total Number of Preference Shareholders with Vote Right
0
Reporting Period
number of B share shareholders is 11,378)
Restored (if any) as of the End of the Reporting Period
Shareholding of Top 10 Shareholders (Excluding the Shares Lent through Refinancing)
Name of
Shareholder
Nature of Shareholder
Holding Percentage (%)
Number of Shareholding at the End of the Reporting Period
Number of Common Shares Held Subject to Trading Moratorium
Pledged, Marked or Frozen Shares
Status of Shares
Status of Shares
Syngenta Group Co., Ltd.
State-owned Legal Person
78.47%
1,828,137,961
--
--
--
China Structural Reform Fund
State-owned Legal Person
1.44%
33,557,046
--
--
--
China Cinda Asset Management Co.,
Ltd.
State-owned Legal Person
1.34%
31,115,916
--
--
--
Hong Kong Securities Clearing
Company Ltd. (HKSCC)
Overseas
Legal Person
0.62%
14,414,719
--
--
--
Wu Feng
Domestic Natural Person
0.34%
7,863,412
--
--
--
Zhu Shenglan
Domestic Natural
Person
0.32%
7,350,000
--
--
--
Qichun County
State-owned Assets Center
State-owned Legal Person
0.18%
4,169,266
Liu Minqin
Domestic Natural Person
0.16%
3,832,446
--
--
--
Zhang Jianwei
Domestic Natural Person
0.13%
3,109,701
--
--
--
GUOTAI JUNAN SECURITIES
(HONG KONG) LIMITED
Overseas
Legal Person
0.13%
3,006,597
--
--
--
Shares Held by Top 10 Shareholders Not Subject to Trading Moratorium (Excluding the Shares Lent through Refinancing and Restricted Shares of Executives)
Name of Shareholders
Number of Shares Held Not Subject
to Trading Moratorium at the End of the Period
Type of Shares
Type of Shares
Amount
Syngenta Group Co., Ltd.
1,828,137,961
RMB Ordinary Share
1,828,137,961
China Structural Reform Fund
33,557,046
RMB Ordinary Share
33,557,046
China Cinda Asset
Management Co., Ltd.
31,115,916
RMB Ordinary Share
31,115,916
Hong Kong Securities
Clearing Company Ltd. (HKSCC)
14,414,719
RMB Ordinary Share
14,414,719
Wu Feng
7,863,412
RMB Ordinary Share
7,863,412
Zhu Shenglan
7,350,000
RMB Ordinary Share
7,350,000
Qichun County State-owned Assets Center
4,169,266
RMB Ordinary Share
4,169,266
Liu Minqin
3,832,446
RMB Ordinary Share
3,832,446
Zhang Jianwei
3,109,701
RMB Ordinary Share
3,109,701
GUOTAI JUNAN SECURTIES (HONG KONG) LIMITED
3,006,597
Domestically Listed Shares in Foreign Currencies
3,006,597
Explanation on associated relationship among the above-mentioned
shareholders, or
Syngenta Group Co., Ltd. is neither a related party to any other shareholders listed above, nor any acting-in-concert party as prescribed in the Administrative Methods for Acquisition of Listed Companies. It is unknown whether the other shareholders are related parties or
acting-in-concert parties as prescribed in the Administrative Methods for Acquisition of Listed
explanation on acting-in-concert
Companies.
Particular about the top ten shareholder participating in the securities financing business (if any)
Shareholder Wu Feng held 4,882,586 shares of the Company through a common securities account and 2,980,826 shares of the Company through a credit collateral securities trading account, altogether 7,863,412 shares. Shareholder Liu Minqin held 403,746 shares of the Company through a common securities account of the Company and 3,428,700 shares of the Company through a credit collateral securities trading account, altogether 3,832,446
shares.
Shareholders holding more than 5% of shares, top ten shareholders and top ten shareholders with unlimited shares in circulation participating in the shares lending through refinancing arrangement
□Applicable √ Not applicable
Change of top ten shareholders and top ten shareholders with unlimited shares in circulation from the previous period due to the shares lending/returning through refinancing arrangement
Applicable √ Not applicable
Total number of preference shareholders and shareholdings of the top 10 of such at the period-end
Applicable √ Not applicable
Other Significant Events
Applicable √ Not applicable
Financial Statements
Financial Statements
Consolidated balance sheet
Prepared by ADAMA Ltd.
30 September 2025
Unit: RMB'000
Item
September 30,
2025
December 31,
2024
Item
September 30,
2025
December 31,
2024
Current assets:
Current liabilities:
Cash at bank and on hand
3,734,324
3,630,608
Short-term loans
6,394,069
4,748,720
Financial assets held for trading
12,641
1,035
Derivative financial liabilities
291,732
278,580
Derivative financial assets
334,747
483,822
Bills payable
647,860
439,495
Bills receivable
147,568
65,565
Accounts payable
5,309,492
4,934,865
Accounts receivable
7,804,471
7,977,830
Contract liabilities
1,493,561
1,810,764
Receivables financing
96,351
144,763
Employee benefits payable
808,113
851,784
Prepayments
342,295
313,542
Taxes payable
449,404
516,761
Other receivables
640,870
1,147,469
Other payables
1,872,012
1,417,319
Inventories
11,968,957
11,164,663
Non-current liabilities due within one year
1,998,547
2,230,713
Other current assets
1,180,676
988,093
Other current liabilities
1,203,799
784,456
Total current assets
26,262,900
25,917,390
Total current liabilities
20,468,589
18,013,457
Non-current assets:
Non-current liabilities:
Long-term receivables
351,126
159,813
Long-term loans
1,442,948
2,166,625
Long-term equity investments
38,839
30,227
Debentures payable
5,281,141
6,320,157
Other equity investments
130,606
131,473
Lease liabilities
628,209
610,415
Investment properties
19,280
20,509
Long-term accounts payable
176,635
191,103
Fixed assets
9,547,158
9,762,895
Long-term employee benefits payables
536,835
543,855
Construction in progress
1,822,558
1,996,892
Provisions
391,690
316,490
Right-of-use assets
547,539
557,159
Deferred tax liabilities
204,862
283,081
Intangible assets
4,389,981
4,796,655
Other non-current liabilities
2,346,379
2,623,500
Goodwill
5,017,236
5,074,283
Total non-current liabilities
11,008,699
13,055,226
Deferred tax assets
1,452,771
1,291,654
Total liabilities
31,477,288
31,068,683
Other non-current assets
350,639
320,827
Shareholders' equity:
Total non-current assets
23,667,733
24,142,387
Share capital
2,329,812
2,329,812
Total assets
49,930,633
50,059,777
Capital reserves
12,950,464
12,950,464
Other comprehensive income
1,687,420
1,721,028
Special reserves
3,576
10,798
Surplus reserves
298,610
298,610
Retained earnings
1,183,463
1,680,382
Total equity attributed to the shareholders of the company
18,453,345
18,991,094
Non-controlling interests
-
-
Total equity
18,453,345
18,991,094
Total liabilities and equity
49,930,633
50,059,777
Gael Hili
Legal representative
Efrat Nagar
Chief of the accounting work
Efrat Nagar
Chief of the accounting organ
Consolidated income statement for the period from the year-beginning to the end of the Reporting Period
Unit: RMB'000
Item
January-September, 2025
January-September, 2024
1. Total operating Income
21,678,425
21,523,293
Less: Cost of sales
16,004,956
16,748,146
Taxes and surcharges
72,462
71,856
Selling and Distribution expenses
2,950,375
3,408,333
General and Administrative expenses
1,089,510
817,172
Research and Development expenses
307,417
319,977
Financial expenses
1,544,466
1,220,073
Including: Interest expense
527,096
792,488
Interest income
101,281
181,974
Add: Investment income, net
7,464
8,386
Including: Income from investment in associates
and joint ventures
7,464
6,062
Gain (Loss) from changes in fair value
4,781
(235,775)
Credit impairment losses
(108,746)
(85,475)
Asset Impairment losses
(63,997)
(157,247)
Gain from disposal of assets
14,599
39,823
2. Operating loss
(436,660)
(1,492,552)
Add: Non-operating income
38,793
69,143
Less: Non-operating expense
19,579
19,195
3. Total loss
(417,446)
(1,442,604)
Less: income tax expense (income)
5,360
395,508
4. Net loss
(422,806)
(1,838,112)
4.1 Classified by nature of operations
4.1.1 Continuing operations
(422,806)
(1,838,112)
4.2 Classified by ownership
4.2.1 Shareholders of the Company
(422,806)
(1,838,112)
4.2.2 Non-controlling interests
-
-
5. Other comprehensive income (loss) net of tax
(33,608)
(229,757)
Other comprehensive income (loss) net of tax attributable to
shareholders of the Company
(33,608)
(229,757)
5.1 Items that will not be reclassified into profit/loss
(2,882)
4,545
5.1.1 Re-measurement of defined benefit plan liability
(2,882)
4,545
5.2 Items that were or will be reclassified to profit or loss
(30,726)
(234,302)
5.2.1 Effective portion of gains or loss of cash flow hedge
(35,542)
(7,805)
5.2.2 Translation differences of foreign financial statements
4,816
(226,497)
Other comprehensive income net of tax attributable to Non-controlling
interests
-
-
6. Total comprehensive loss for the period
(456,414)
(2,067,869)
Total comprehensive loss attributable to shareholders
of the Company
(456,414)
(2,067,869)
Total comprehensive income attributable to Non-controlling interests
-
-
7. Earnings (loss) per share
7.1 Basic earnings (loss) per share (RMB/ share)
(0.1815)
(0.7890)
7.2 Diluted earnings per share (RMB/ share)
N/A
N/A
Gael Hili
Legal representative
Efrat Nagar
Chief of the accounting work
Efrat Nagar
Chief of the accounting organ
Consolidated cash flow statement for the period from the year-beginning to the end of the Reporting Period
Unit: RMB'000
Item
January-September, 2025
January-September, 2024
1. Cash flows from operating activities:
Cash received from sale of goods and rendering of services
22,008,090
20,852,442
Refund of taxes and surcharges
167,870
165,239
Cash received relating to other operating activities
105,894
343,229
Sub-total of cash inflows from operating activities
22,281,854
21,360,910
Cash paid for goods and services
14,138,110
12,964,858
Cash paid to and on behalf of employees
2,906,459
2,997,725
Payments of taxes and surcharges
435,698
428,866
Cash paid relating to other operating activities
2,427,727
2,107,229
Sub-total of cash outflows from operating activities
19,907,994
18,498,678
Net cash flows from operating activities
2,373,860
2,862,232
2. Cash flows from investing activities :
Cash receipts from disposal of investments
55,050
83,249
Cash received from investment income
3,301
-
Net cash received from disposal of fixed assets, intangible assets
and other long-term assets
46,283
242,278
Cash received for other investing activities
-
2,325
Sub-total of cash inflows from investing activities
104,634
327,852
Cash paid to acquire fixed assets, intangible assets and other
long-term assets
865,720
1,074,140
Net cash paid to acquire subsidiaries or other business units
56,272
-
Cash paid for other investing activities
124,725
120,132
Sub-total of cash outflows from investing activities
1,046,717
1,194,272
Net cash flows from investing activities
(942,083)
(866,420)
3. Cash flows from financing activities:
Cash received from borrowings
1,835,663
1,311,257
Cash received relating to other financing activities
1,652,577
805,600
Sub-total of cash inflows from financing activities
3,488,240
2,116,857
Cash repayment of borrowings
3,664,529
3,588,782
Cash payment for dividends, profit distributions or interest
698,885
788,921
Including: dividends paid to non-controlling interest
74,113
69,512
Cash paid relating to other financing activities
533,136
442,213
Sub-total of cash outflows from financing activities
4,896,550
4,819,916
Net cash flows from financing activities
(1,408,310)
(2,703,059)
4. Effect of foreign exchange rate changes on cash and cash
equivalents
(27,731)
(21,111)
5. Net increase (decrease) in cash and cash equivalents
(4,264)
(728,358)
Add: Cash and cash equivalents at the beginning of the period
3,583,963
4,857,358
6. Cash and cash equivalents at the end of the period
3,579,699
4,129,000
Impact of initial application of new accounting standards on the opening balances of current year
Applicable √ Not applicable
Auditor's report
Is this Report audited?
Yes √ No
This Report is unaudited.
Board of Directors ADAMA Ltd.
October 30, 2025